Greatbatch Sets Up Shop In Singapore: Targets Emerging Markets
Executive Summary
In July, Greatbatch Inc. announced that its QiG Group established a research and development center in Singapore, with a focus on the development of active implantable medical devices, that is, the kinds of devices that are powered by batteries or other sources. Greatbatch thus sets up a regional presence that will help it develop medical devices that address the specific needs of emerging markets in the Asia-Pacific region. The Singapore initiative is also a stake in the ground for Greatbatch’s strategy to remake itself and the medical device industry.